Project Grant HT94252510197
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
The U.S. Department of the Army Medical Command awarded a $577,680.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Regents of the University of Colorado (CU) on May 1, 2025. The grant supports CU's research to Target EHMT1/2 to Overcome Therapy-Resistant Ovarian Cancer, with an ultimate completion date of April 30, 2029. As a prominent public research university, CU has an extensive history of federal contract and grant work...
The University of Colorado Denver was awarded a $466,494 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a research project examining the role of the tumor microbiome in mucosal melanoma development and antitumor immunity. The study aims to transform health care for service members and the public by investigating medical solutions for the battlefield through innovative and impactful biomedical...
The University of Colorado Denver was awarded a $3,067,768 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420) to investigate the mechanisms underlying brain metastatic progression in ER+ breast cancer. The three-year award running from September 1, 2022 to August 31, 2025 will support research into medical solutions for the battlefield by transforming healthcare through innovative and impactful...
The University of Colorado-Denver has been awarded a $1,130,984 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "DEFINING AND TARGETING CHROMOBOX2 (CBX2)-MEDIATED CHEMORESISTANCE IN HIGH GRADE SEROUS CARCINOMA". The grant will support the university's research efforts to investigate novel approaches for overcoming chemoresistance in high-grade serous carcinoma, a form of ovarian cancer, over a...
The Regents of the University of Colorado received a $949,216 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from July 1, 2021 to June 30, 2025 to define a novel therapeutic application of lactoferrin for intestinal inflammation. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Regents of the University of Colorado received a $2,121,871 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The four-year award will support research defining a novel therapeutic application of lactoferrin for intestinal inflammation from July 1, 2021 to June 30, 2025. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $780,000.00 to The Regents of the University of Colorado, doing business as the University of Colorado-Denver, to support research on "An Unconventional Pathway to Melanoma Development and Prevention". The research aims to investigate innovative approaches to address melanoma, a serious form of skin cancer, with the goal of improving...
This federal Project Grant award in the amount of $2,271,024.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research aimed at understanding next-generation immunotherapy responses in metastatic uveal melanoma. The award, with a performance period from November 1, 2024 to October 31, 2028, is provided to the University of Colorado-Denver, a prominent public research university, to conduct advanced biomedical research...
This $2,488,002.00 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports a multi-year research effort by the University of Colorado-Denver to develop biomarkers for detecting acute, subacute, and chronic organ injury following neonatal congenital heart disease surgery. The research aims to improve diagnostic capabilities and treatment outcomes for this patient population. The award runs from April 1, 2024 to March 31, 2028, and...
This federal Project Grant award in the amount of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Colorado-Denver. The grant will fund a 2-year project from July 1, 2024 to June 30, 2026 to investigate the use of cell-free DNA to define MYC activity in osteosarcoma. The University of Colorado-Denver, a major public research institution, will serve as the primary awardee and perform the research...